What Makes Medtronic a Leader in Medical Devices

Medtronic plc (NYSE:MDT) is one of the Best Wide Moat Dividend Stocks to Invest in.

The company remains a major player in the medical technology space as it focuses on medical devices. Its broad product lineup targets a variety of chronic conditions, including heart disease, diabetes, chronic pain, and acute care needs. With strengths across several therapeutic areas, the company has multiple paths for growth and holds a strong position in each market it serves.

R&D is key in healthcare, often drawing attention to smaller companies with breakthrough potential, but they carry high risk and usually don’t pay dividends. Medtronic plc (NYSE:MDT) stands out as a stable, mature firm that offers a dividend. The company has raised its payouts for 48 consecutive years, which means that it’s just two years away from becoming a Dividend King. The company pays a quarterly dividend of $0.71 per share and has a dividend yield of 3.30%, as of June 24.

Medtronic plc (NYSE:MDT) recently announced that it will spin off its diabetes care division into an independent, publicly traded company within the next 18 months. The move is part of its strategy to streamline operations and focus on core, high-margin growth areas.

Although it will part with its fastest-growing segment, Medtronic plc (NYSE:MDT)’s overall business remains strong, with a broad portfolio of products that continue to deliver steady revenue and profits. In a tough market, investors often favor reliable, stable companies like Medtronic.

While we acknowledge the potential of MDT as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 10 Best Dividend Stocks for a Bear Market and 10 Best Dividend Stocks to Buy for Dependable Dividend Growth.

Disclosure. None.